NewEdge Advisors LLC Boosts Holdings in Healthpeak Properties, Inc. $DOC

Key Points

• NewEdge Advisors increased its Healthpeak Properties position by 1,063.5% in the first quarter, purchasing 108,615 additional shares and bringing its holdings to 118,828 shares valued at approximately $1.95 million. Institutional investors collectively own 93.57% of DOC stock.
• Analysts raised several price targets, including BMO Capital Markets and RBC to $24, but the overall consensus remains “Hold”, with an average target price of $21.44.
• Healthpeak exceeded quarterly earnings and revenue expectations, reporting $0.08 EPS on $771.58 million in revenue. The REIT also announced a monthly dividend of $0.1017 per share, representing an annualized yield of approximately 5.9%.

NewEdge Advisors LLC boosted its position in shares of Healthpeak Properties, Inc. (NYSE:DOC - Free Report) by 1,063.5% during the 1st quarter, according to its most recent 13F filing with the SEC. The fund owned 118,828 shares of the real estate investment trust's stock after purchasing an additional 108,615 shares during the quarter. NewEdge Advisors LLC's holdings in Healthpeak Properties were worth $1,952,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also bought and sold shares of the company. WPG Advisers LLC grew its holdings in shares of Healthpeak Properties by 270.2% during the fourth quarter. WPG Advisers LLC now owns 1,640 shares of the real estate investment trust's stock valued at $26,000 after buying an additional 1,197 shares during the last quarter. Advocate Investing Services LLC bought a new stake in shares of Healthpeak Properties during the fourth quarter valued at approximately $26,000. Elyxium Wealth LLC purchased a new position in Healthpeak Properties in the 4th quarter worth approximately $31,000. Clearstead Advisors LLC raised its holdings in Healthpeak Properties by 166.3% in the 4th quarter. Clearstead Advisors LLC now owns 1,947 shares of the real estate investment trust's stock worth $31,000 after acquiring an additional 1,216 shares during the last quarter. Finally, CYBER HORNET ETFs LLC bought a new position in Healthpeak Properties in the 2nd quarter valued at approximately $33,000. 93.57% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several analysts have commented on DOC shares. BMO Capital Markets increased their target price on Healthpeak Properties from $20.00 to $24.00 and gave the company an "outperform" rating in a research note on Monday, June 15th. Wells Fargo & Company boosted their price target on Healthpeak Properties from $20.00 to $22.00 and gave the stock an "equal weight" rating in a research note on Wednesday, July 15th. Royal Bank Of Canada upped their price target on Healthpeak Properties from $21.00 to $24.00 and gave the company an "outperform" rating in a report on Monday, August 10th. UBS Group increased their price objective on Healthpeak Properties from $19.00 to $21.50 and gave the company a "neutral" rating in a research report on Wednesday, July 8th. Finally, JPMorgan Chase & Co. boosted their target price on Healthpeak Properties from $18.00 to $21.00 and gave the stock a "neutral" rating in a research report on Wednesday, June 24th. Four equities research analysts have rated the stock with a Buy rating and fifteen have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of "Hold" and a consensus price target of $21.44.

Healthpeak Properties Stock Down 0.1%

Shares of Healthpeak Properties stock opened at $20.78 on Friday. Healthpeak Properties, Inc. has a twelve month low of $15.70 and a twelve month high of $22.95. The company has a quick ratio of 3.02, a current ratio of 3.02 and a debt-to-equity ratio of 1.06. The company's 50 day moving average is $21.33 and its 200 day moving average is $18.90. The company has a market cap of $14.33 billion, a price-to-earnings ratio of 59.38, a price-to-earnings-growth ratio of 3.20 and a beta of 1.01.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Tuesday, August 4th. The real estate investment trust reported $0.08 earnings per share for the quarter, beating analysts' consensus estimates of $0.03 by $0.05. The business had revenue of $771.58 million during the quarter, compared to analyst estimates of $725.64 million. Healthpeak Properties had a net margin of 8.24% and a return on equity of 2.79%. The company's quarterly revenue was up 11.1% compared to the same quarter last year. During the same period in the previous year, the business earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.730-1.770 EPS. Research analysts anticipate that Healthpeak Properties, Inc. will post 1.77 EPS for the current year.

Healthpeak Properties Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Friday, September 25th. Shareholders of record on Monday, September 14th will be issued a $0.1017 dividend. The ex-dividend date of this dividend is Monday, September 14th. This represents a c) dividend on an annualized basis and a yield of 5.9%. Healthpeak Properties's dividend payout ratio is currently 348.57%.

Healthpeak Properties Company Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source